RethinkPeptides
ArticlesTopicsResearch

Neurodegenerative Peptides

3 articles in this topic.

Complete Guides

Neurodegenerative PeptidesGuide

Amyloid-Beta: The Alzheimer's Peptide Explained

Amyloid-beta drives plaque formation in Alzheimer's disease. Review of the amyloid hypothesis, lecanemab and donanemab trials, and peptide-based therapies.

18 min read|Mar 20, 2026

All Articles

Neurodegenerative Peptides

Peptide Approaches to Alzheimer's Disease

Review of peptide-based Alzheimer's therapeutics: amyloid-beta breakers, tau aggregation inhibitors, GLP-1 agonists, neuroprotective peptides, and vaccines.

14 min read|Mar 25, 2026
Neurodegenerative Peptides

Peptide Vaccines for Alzheimer's Disease

Peptide vaccines for Alzheimer's target amyloid-beta fragments to generate antibodies that clear brain plaques. ABvac40 showed positive phase 2 results.

13 min read|Mar 25, 2026

RethinkPeptides

Evidence-based peptide education. No hype, no sales. Just science.

Navigate

All ArticlesTopicsResearch DatabaseEvidence MethodologyDownload DataSearch

About

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of Use

Disclaimer

Content on RethinkPeptides is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider. Peptides discussed here may not be approved for human use in your jurisdiction.

© 2026 RethinkPeptides. All rights reserved.